With clinical studies demonstrating near-total protection, lenacapavir has been described by some health officials as a turning point for high-risk groups.
Tags
There’s no content to show here yet.
Latest Stories
- Zimbabwe roll-out of long-acting HIV prevention drug gets underway
- Iran says it will not bow to pressure from United States over nuclear deal
- Uganda’s Museveni holds talks with Sudan’s RSF leader amid push to end war
- Eastern DR Congo situation ‘catastrophic’, says visiting EU commissioner
- Fasting together: Ramadan and Lent in Sierra Leone’s spirit of harmony
- WFP warns of imminent end to food aid in Somalia without new funding
- Investigation: Russian spy agency takes over Wagner operations in Africa
- Cameroon jails three soldiers involved in killing 21 civilians in 2020
- Trump imposes new 10% tariffs following Supreme Court ruling
- Gabonese presidency defends social media shutdown
Recent Comments
No comments to show.
Leave a Reply